GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Equity-to-Asset

Biohit Oyj (OHEL:BIOBV) Equity-to-Asset : 0.73 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biohit Oyj's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €9.43 Mil. Biohit Oyj's Total Assets for the quarter that ended in Dec. 2023 was €12.92 Mil. Therefore, Biohit Oyj's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.73.

The historical rank and industry rank for Biohit Oyj's Equity-to-Asset or its related term are showing as below:

OHEL:BIOBV' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.68   Med: 0.83   Max: 0.91
Current: 0.73

During the past 13 years, the highest Equity to Asset Ratio of Biohit Oyj was 0.91. The lowest was 0.68. And the median was 0.83.

OHEL:BIOBV's Equity-to-Asset is ranked better than
57.32% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs OHEL:BIOBV: 0.73

Biohit Oyj Equity-to-Asset Historical Data

The historical data trend for Biohit Oyj's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj Equity-to-Asset Chart

Biohit Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.81 0.76 0.68 0.73

Biohit Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.68 0.68 0.72 0.73

Competitive Comparison of Biohit Oyj's Equity-to-Asset

For the Biotechnology subindustry, Biohit Oyj's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohit Oyj's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's Equity-to-Asset falls into.



Biohit Oyj Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biohit Oyj's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=9.425/12.92
=0.73

Biohit Oyj's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=9.425/12.92
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj  (OHEL:BIOBV) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Biohit Oyj Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohit Oyj (OHEL:BIOBV) Business Description

Traded in Other Exchanges
N/A
Address
Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines